OMNICYTE LTD has a total of 18 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are CHANGCHUN HUAPU BIOTECHNOLOGY, IDERA PHARMACEUTICALS and TOPIGEN PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Gordon Myrtle | 13 |
#2 | Habib Nagy | 9 |
#3 | Habib Nagy A | 2 |
#4 | Myrtle Gordon | 1 |
#5 | Nagy Habib | 1 |
Publication | Filing date | Title |
---|---|---|
WO2012046065A2 | Culture method for culturing pluripotent cells comprising an inhibitor of mirna- 181a* | |
GB201021435D0 | Method | |
GB201016856D0 | Method | |
GB0901675D0 | Cells | |
GB0329449D0 | Stem cells |